Effectiveness of montelukast plus bilastine vs montelukast plus levocetirizine in allergic rhinitis.
- Conditions
- Health Condition 1: J309- Allergic rhinitis, unspecified
- Registration Number
- CTRI/2024/08/071971
- Lead Sponsor
- Dr Ganesh Dakhale
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Patients suffering from non-specific allergic rhinitis of either gender, in age group 18 to 65 years.
2. History of intermittent or persistent allergic rhinitis of any severity with no obvious cause prior to inclusion in study.
3. Patients with TNSS greater than 8 not treated with anti-histamines in last 7 days.
1. History of asthma requiring chronic use of inhaled corticosteroids.
2. Had been unresponsive to anti-histamine in the past.
3. History of allergy to the study medication or unable to tolerate anti-histamines.
4. Use of study drug in last 1 week prior to baseline.
5. Pregnant and nursing women.
6. Subjects with history of significant haematopoietic, hepatic, renal, cardiovascular, neurological, psychiatric or autoimmune disease.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in total nasal symptom score (TNSS)Timepoint: at baseline, week 2, week 4
- Secondary Outcome Measures
Name Time Method umber of adverse events in group A & Group BTimepoint: during 4 weeks of study period;To compare Cost effectiveness ratio between group A & group BTimepoint: at 4 weeks